| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16132 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C40B30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5123
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-766
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-763
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate |
2017-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2020-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-102181991-B1 |
| titleOfInvention |
Nano-perforator and pharmaceutical composition comprising the same for preventing or treating viral infection |
| abstract |
The present invention relates to a nanoperforator comprising a lipid bilayer nanodisk and a membrane-structured protein surrounding the nanodisc, and a pharmaceutical composition for preventing or treating viral infections comprising the nanoperforator as an active ingredient. If the lipid bilayer nanoperforator provided in the present invention is used, it is possible to safely prevent or treat diseases caused by virus infection regardless of whether or not the virus is mutated, so it will be widely used for safe and effective treatment of viral infections. . |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023158159-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102540330-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102540331-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102438720-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102438721-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023158158-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022225268-A1 |
| priorityDate |
2016-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |